Viatris Inc [VTRS] - / Pacira BioSciences merger
Viatris Inc. has entered into a definitive merger agreement to acquire Pacira BioSciences, Inc. for $36.50 per share in cash, with the tender offer expected to remain open for 10 business days.
Why this matters
Viatris Inc., a pharmaceutical company known for its broad portfolio of medications and healthcare products, has entered into a definitive merger agreement to acquire Pacira BioSciences, Inc., a company specializing in non-opioid pain management and regenerative health solutions. This acquisition is structured as a cash transaction, with Viatris offering $36.50 per share for Pacira's outstanding shares. The tender offer for Pacira's shares is expected to remain open for 10 business days, providing shareholders with a limited window to tender their shares under the terms of the agreement.